Cargando…
TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors
Histone deacetylases (HDACs) have been implicated in multiple malignant tumors, and HDAC inhibitors (HDACIs) exert anti-cancer effects. However, the expression of HDACs and the anti-tumor mechanism of HDACIs in cholangiocarcinoma (CCA) have not yet been elucidated. In this study, we found that expre...
Autores principales: | He, Jun-chuang, Yao, Wei, Wang, Jian-ming, Schemmer, Peter, Yang, Yan, Liu, Yan, Qian, Ya-wei, Qi, Wei-peng, Zhang, Jian, Shen, Qi, Yang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342751/ https://www.ncbi.nlm.nih.gov/pubmed/27705912 http://dx.doi.org/10.18632/oncotarget.12254 |
Ejemplares similares
-
TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis
por: Du, Yong, et al.
Publicado: (2016) -
High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis
por: Huang, Zhi-Liang, et al.
Publicado: (2015) -
Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females
por: Huang, Yixiang, et al.
Publicado: (2018) -
High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis
por: Shakya, Manjul, et al.
Publicado: (2018) -
14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/snail signaling pathway
por: Yang, Yan, et al.
Publicado: (2016)